The skull marrow–meninges–brain interface in Alzheimer’s disease with a focus on amyloid-associated immune remodeling

Skull bone marrow supplies immune cells to CNS borders and receives signals through cerebrospinal fluid (CSF)-associated routes. This interface may contribute to Alzheimer’s disease (AD), but its anatomical connectivity is better established than its disease-specific functions. This narrative review examines five processes: sensing, hematopoiesis, trafficking, effector functions, and translation, with a focus on amyloid-associated evidence. We distinguish human observations, skull-specific experiments, and findings from systemic marrow or other CNS disorders. Human molecular profiling and PET studies support regional skull-marrow differences and disease-associated signals; they do not establish cell migration or causality. In AD mouse models, Aβ-associated IL-6 signaling promotes B-lineage responses, whereas osteoblast-dependent niche and channel remodeling alters myeloid trafficking. These findings support distinct, potentially interacting mechanisms rather than a single established pathway. Monocyte-derived macrophages are distinguished from embryonically derived resident populations, and skull-to-dura channels are separated from routes across the arachnoid. Local Aβ production, circulating exposure, and CSF-associated delivery remain competing explanations for marrow accumulation. Tau pathology and sex-dependent border immunity are relevant modifiers, but direct evidence linking them to skull-specific hematopoietic responses remains limited. We use “cranial hematopoietic reprogramming” as a working hypothesis and treat stage, lineage, genotype, and experimental context as separate determinants of outcome. Source-specific tracing and longitudinal, sex-stratified studies are needed before skull-marrow measurements or interventions can be assigned clinical value.

Authors

Institutions

Publication Details

Journal
Frontiers in Aging Neuroscience
Published
2026-11-16
DOI
https://doi.org/10.3389/fnagi.2026.2013438
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The skull marrow–meninges–brain interface in Alzheimer’s disease with a focus on amyloid-associated immune remodeling

Zhaoyang Yang, Jiaqi Wu, Xin Xiong
5 links
Frontiers in Aging Neuroscience
Neuroinflammation and Neurodegeneration Mechanisms
article

The skull marrow–meninges–brain interface in Alzheimer’s disease with a focus on amyloid-associated immune remodeling

Zhaoyang Yang, Jiaqi Wu, Xin Xiong
article en

Abstract

Skull bone marrow supplies immune cells to CNS borders and receives signals through cerebrospinal fluid (CSF)-associated routes. This interface may contribute to Alzheimer’s disease (AD), but its anatomical connectivity is better established than its disease-specific functions. This narrative review examines five processes: sensing, hematopoiesis, trafficking, effector functions, and translation, with a focus on amyloid-associated evidence. We distinguish human observations, skull-specific experiments, and findings from systemic marrow or other CNS disorders. Human molecular profiling and PET studies support regional skull-marrow differences and disease-associated signals; they do not establish cell migration or causality. In AD mouse models, Aβ-associated IL-6 signaling promotes B-lineage responses, whereas osteoblast-dependent niche and channel remodeling alters myeloid trafficking. These findings support distinct, potentially interacting mechanisms rather than a single established pathway. Monocyte-derived macrophages are distinguished from embryonically derived resident populations, and skull-to-dura channels are separated from routes across the arachnoid. Local Aβ production, circulating exposure, and CSF-associated delivery remain competing explanations for marrow accumulation. Tau pathology and sex-dependent border immunity are relevant modifiers, but direct evidence linking them to skull-specific hematopoietic responses remains limited. We use “cranial hematopoietic reprogramming” as a working hypothesis and treat stage, lineage, genotype, and experimental context as separate determinants of outcome. Source-specific tracing and longitudinal, sex-stratified studies are needed before skull-marrow measurements or interventions can be assigned clinical value.

Frontiers in Aging NeuroscienceVol. 18
Fujian University of Traditional Chinese Medicine (CN)
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon